269 related articles for article (PubMed ID: 9714055)
1. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer.
Kleeff J; Ishiwata T; Friess H; Büchler MW; Korc M
Int J Cancer; 1998 Sep; 77(6):860-8. PubMed ID: 9714055
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of activin A in stage IV colorectal cancer.
Wildi S; Kleeff J; Maruyama H; Maurer CA; Büchler MW; Korc M
Gut; 2001 Sep; 49(3):409-17. PubMed ID: 11511564
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE).
Choi KC; Kang SK; Nathwani PS; Cheng KW; Auersperg N; Leung PC
Mol Cell Endocrinol; 2001 Mar; 174(1-2):99-110. PubMed ID: 11306176
[TBL] [Abstract][Full Text] [Related]
4. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
[TBL] [Abstract][Full Text] [Related]
5. Expression and localization of inhibin/activin subunits and activin receptors in MCF-7 cells, a human breast cancer cell line.
Ying SY; Zhang Z
Breast Cancer Res Treat; 1996; 37(2):151-60. PubMed ID: 8750582
[TBL] [Abstract][Full Text] [Related]
6. Human testicular germ cell tumours express inhibin subunits, activin receptors and follistatin mRNAs.
van Schaik RH; Wierikx CD; Looijenga LH; Oosterhuis JW; de Jong FH
Br J Cancer; 1997; 76(9):1191-8. PubMed ID: 9365168
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of inhibin signal transduction.
Bernard DJ; Chapman SC; Woodruff TK
Recent Prog Horm Res; 2001; 56():417-50. PubMed ID: 11237224
[TBL] [Abstract][Full Text] [Related]
8. Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma.
Petraglia F; Florio P; Luisi S; Gallo R; Gadducci A; Viganò P; Di Blasio AM; Genazzani AR; Vale W
J Clin Endocrinol Metab; 1998 Apr; 83(4):1194-200. PubMed ID: 9543140
[TBL] [Abstract][Full Text] [Related]
9. Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues.
van Schaik RH; Wierikx CD; Timmerman MA; Oomen MH; van Weerden WM; van der Kwast TH; van Steenbrugge GJ; de Jong FH
Br J Cancer; 2000 Jan; 82(1):112-7. PubMed ID: 10638976
[TBL] [Abstract][Full Text] [Related]
10. Localization of inhibins and activins in normal endocrine cells and endocrine tumors of the gut and pancreas: an immunohistochemical and in situ hybridization study.
La Rosa S; Uccella S; Marchet S; Capella C; Lloyd RV
J Histochem Cytochem; 2004 Feb; 52(2):217-25. PubMed ID: 14729874
[TBL] [Abstract][Full Text] [Related]
11. Activin-related proteins in bovine mammary gland: localization and differential expression during gestational development and differentiation.
Bloise E; Cassali GD; Ferreira MC; Ciarmela P; Petraglia F; Reis FM
J Dairy Sci; 2010 Oct; 93(10):4592-601. PubMed ID: 20854993
[TBL] [Abstract][Full Text] [Related]
12. Expression and localization of inhibin alpha, inhibin/activin betaA and betaB and the activin type II and inhibin beta-glycan receptors in the developing human testis.
Anderson RA; Cambray N; Hartley PS; McNeilly AS
Reproduction; 2002 Jun; 123(6):779-88. PubMed ID: 12052232
[TBL] [Abstract][Full Text] [Related]
13. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.
Lebrun JJ; Vale WW
Mol Cell Biol; 1997 Mar; 17(3):1682-91. PubMed ID: 9032295
[TBL] [Abstract][Full Text] [Related]
14. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism.
Xu J; McKeehan K; Matsuzaki K; McKeehan WL
J Biol Chem; 1995 Mar; 270(11):6308-13. PubMed ID: 7890768
[TBL] [Abstract][Full Text] [Related]
15. Activin A stimulates type IV collagenase (matrix metalloproteinase-2) production in mouse peritoneal macrophages.
Ogawa K; Funaba M; Mathews LS; Mizutani T
J Immunol; 2000 Sep; 165(6):2997-3003. PubMed ID: 10975808
[TBL] [Abstract][Full Text] [Related]
16. Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms.
Hofland J; Timmerman MA; de Herder WW; van Schaik RH; de Krijger RR; de Jong FH
Clin Endocrinol (Oxf); 2006 Dec; 65(6):792-9. PubMed ID: 17121532
[TBL] [Abstract][Full Text] [Related]
17. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
[TBL] [Abstract][Full Text] [Related]
18. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
[TBL] [Abstract][Full Text] [Related]
19. Activin and inhibin binding to the soluble extracellular domain of activin receptor II.
Donaldson CJ; Vaughan JM; Corrigan AZ; Fischer WH; Vale WW
Endocrinology; 1999 Apr; 140(4):1760-6. PubMed ID: 10098513
[TBL] [Abstract][Full Text] [Related]
20. Expression and localization of activin receptors during endochondral bone development.
Funaba M; Ogawa K; Abe M
Eur J Endocrinol; 2001 Jan; 144(1):63-71. PubMed ID: 11174839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
